Klotho modulation
Described is a low voltage, pulsed electrical stimulation device for controlling expression of klotho, a useful protein, by tissues. Also described are methods of enhancing expression of klotho in cells.
1. A bioelectric stimulator comprising an electric signal generator and electrodes, which electric signal generator is programmed to produce a bioelectric signal that stimulates target tissue comprising living cells to express and/or release Klotho polypeptide by the living cells of the target tissue,
wherein the bioelectric signal comprises, within 15%, a biphasic pulse at 20 Hz and 7.8 ms pulse duration.
2. The bioelectric stimulator of claim 1 , wherein the bioelectric stimulator is further programmed to produce, within 15%, a bioelectric signal of 30 pulses per second, and successively alternating currents for one minute, and again for one minute, plus stimulated with a pulse of 40 pulses per second, pulse width of 100 μs, and frequency of 100 Hz.
3. The bioelectric stimulator of claim 1 , wherein the bioelectric stimulator is further programmed to produce a bioelectric signal of 10 Hz and pulse duration of 0.2 ms.
4. The bioelectric stimulator of claim 1 , wherein the bioelectric stimulator is further programmed to produce a bioelectric signal of 100 Hz, pulse of 40 pulses/s, and pulse width of 100 μs.
5. The bioelectric stimulator of claim 1 , wherein the bioelectric stimulator is further programmed to produce, within 15%, a bioelectric signal of 50 Hz and a bioelectric signal of 100 Hz.
6. The bioelectric stimulator of claim 1 , wherein the bioelectric stimulator is further programmed to produce a bioelectric signal of 50 Hz alternating electrical field.
7. The bioelectric stimulator of claim 1 , wherein the bioelectric stimulator is further programmed to produce, within 15%, a bioelectric signal with frequency of 22 Hz.
8. A method of using a bioelectric stimulator to stimulate target tissue comprising living cells of a subject, wherein the bioelectric stimulator comprises an electric signal generator and electrodes, and wherein the electric signal generator is programmed to produce a bioelectric signal comprising, within 15%, a biphasic pulse at 20 Hz and 7.8 ms pulse duration, the method comprising:
connecting the bioelectric stimulator to the target tissue of the subject via the electrodes, and
actuating the bioelectric stimulator to produce the programmed bioelectric signal(s) signal so as to stimulate the living cells to express and/or release klotho polypeptide.
9. The method according to claim 8 , wherein the target tissue is selected from the group consisting of muscle, brain, kidney, pancreas, bone, tumor, and nerve.
10. The method according to claim 8 , wherein the subject has been diagnosed as suffering from kidney failure, diabetes, bone degeneration, aging, cancer, and/or immune system dysfunction.
11. The method according to claim 8 , wherein the subject has age-related cognitive decline, cognitive decline resulting from a neurodegenerative disease, and/or cognitive decline resulting from traumatic brain injury.
12. The method according to claim 8 , wherein the subject is receiving or has received radiation treatment or chemotherapy for cancer.
13. A method of treating a cell, the method comprising:
stimulating the cell to express and/or release Klotho polypeptide by applying a bioelectric signal to the cell, wherein the bioelectric signal comprises, within 15%, a biphasic pulse at 20 Hz and 7.8 ms pulse duration.
14. The method according to claim 13 , further comprising stimulating the cell by applying a further bioelectric signal to the cell, wherein the further bioelectric signal comprises 30 pulses per second and successively alternating currents for one minute, and again for one minute, plus stimulated with a pulse of 40 pulses per second, pulse width of 100 μs, and frequency of 100 Hz.
15. The method according to claim 13 , further comprising stimulating the cell by applying a further bioelectric signal to the cell, wherein the further bioelectric signal is 10 Hz and pulse duration of 0.2 ms.
16. The method according to claim 13 , further comprising stimulating the cell by applying a further bioelectric signal to the cell, wherein the further bioelectric signal comprises 100 Hz and pulse of 40 pulses/s, and pulse width of 100 μs.
17. The method according to claim 13 , further comprising stimulating the cell by applying a further bioelectric signal to the cell, wherein the further bioelectric signal comprises, within 15%, 50 Hz and another bioelectric signal of 100 Hz.
18. The method according to claim 13 , further comprising stimulating the cell by applying a further bioelectric signal to the cell, wherein the further bioelectric signal is 50 Hz alternating electrical field for 15 minutes.
19. The method according to claim 13 , further comprising stimulating the cell by applying a further bioelectric signal to the cell with a frequency of, within 15%, 22 Hz, for 15 minutes.
20. The method according to claim 13 , wherein the cell is comprised within a subject.
21. The method according to claim 20 , wherein the subject has been diagnosed as having kidney failure, diabetes, bone degeneration, aging, cancer, and/or immune system dysfunction.